The global migraine drugs market is predicted to grow at a 5.9% CAGR between the forecast period, states the new Market Research Future (MRFR) report. Migraines, simply put, are severe, painful, and recurring headaches, which can be accompanied or preceded by sensory warning symptoms and other signs.